Changes

Jump to navigation Jump to search
no edit summary
Line 83: Line 83:  
|
 
|
 
|-
 
|-
|Juvenile myelomonocytic leukaemia||Disease|| '''Sarah Rapisardo, PhD, FACMG''' |Assistant Professor, Pathology Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories|| || || || ||FQR|| ||
+
|Juvenile myelomonocytic leukaemia||Disease|| '''Sarah Rapisardo, PhD, FACMG''' | || || || || ||FQR|| ||
 +
|Juvenile Myelomonocytic Leukemia (JMML)
 +
|<nowiki>Sarah Rapisardo, PhD, FACMG | Assistant Professor, Pathology</nowiki>
 +
 
 +
Associate Director | Division of Molecular Pathology, Genetics and Genomics
 +
 
 +
Duke University Health System Clinical Laboratories
 +
|PENDING importing content and reference formatting
 
|
 
|
|
+
|FQR has emailed SR several times, last 4/20/22
|
  −
|
  −
|PENDING importing content and reference formatting; FQR has emailed SR several times, last 4/20/22
   
|-
 
|-
|Myeloproliferative neoplasm, NOS||Disease||Thomas Lee, MD, PhD, University of California, Los Angeles|| || || || ||FQR|| ||
+
|Myeloproliferative neoplasm, NOS||Disease|| || || || || ||FQR|| ||
|
+
|Myeloproliferative Neoplasm (MPN), Unclassifiable
|
+
|Thomas Lee, MD, PhD, University of California, Los Angeles
|
+
|Complete
 
|
 
|
 
|
 
|

Navigation menu